Telemedicine for hypertension: opportunities and responsibilities in management

Telemedicine, or non–face-to-face medical treatment, has emerged as an innovative healthcare delivery model that leverages information and communication technologies (ICT) to broaden accessibility, efficiency, and patient convenience. Its effectiveness has been particularly evident in chronic disease management, where long-term monitoring and medication adjustments are essential. Hypertension is the condition most frequently treated through telemedicine among individuals aged over 40 years, exemplifying this suitability. Blood pressure management can be effectively supported through platforms capable of remote monitoring, enabling counseling and medication adjustments without the need for routine physical examinations. In Korea, a leading country in ICT, telemedicine holds strong potential for commercialization and rapid growth. However, current services are often general-purpose platforms designed mainly for administrative simplification and do not align with institutional strategies. There is a need for disease-specific, patient-centered platforms tailored to conditions such as hypertension, in which integrated monitoring of blood pressure and lifestyle factors is critical. Such platforms can partially substitute physical examinations to improve both convenience and clinical outcomes. Despite its advantages, telemedicine has raised significant concerns. Convenience-driven misuse and unresolved issues regarding responsibility, liability, and coordination with pharmacies underscore the need for a clearer legal and institutional framework. In Korea, where healthcare access is already high, the relative urgency may appear lower, yet the commercialization potential remains substantial. Ultimately, telemedicine for chronic diseases should focus on improving patient outcomes, reducing costs, and enhancing patient satisfaction while safeguarding medical professionalism and ethics.